Early research (Phase 1)UnknownNCT02842138What this trial is testingAutologous CD19 CAR T Cells in Relapsed or Refractory B-cell LymphomaWho this might be right forB-cell Lymphoma Peking University 25
Early research (Phase 1)Looking for participantsNCT07478848What this trial is testingRadiation, Oral Vancomycin, and CAR-T for B-Cell LymphomasWho this might be right forLarge B Cell LymphomaNon Hodgkin Lymphoma (NHL)Diffuse Large B Cell Lymphoma (DLBCL)+2 more Abramson Cancer Center at Penn Medicine 14
Not applicableStudy completedNCT05510908What this trial is testingUse of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMCWho this might be right forHIV-Associated Malignant NeoplasmHIV InfectionsCancer+5 more AIDS Malignancy Consortium 460
Testing effectiveness (Phase 2)Looking for participantsNCT03418038What this trial is testingAscorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic LeukemiaWho this might be right forClonal Cytopenia of Undetermined SignificanceHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRecurrent Diffuse Large B-Cell Lymphoma+5 more Mayo Clinic 80
Testing effectiveness (Phase 2)UnknownNCT00333008What this trial is testingA Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.Who this might be right forDiffuse Large B Cell LymphomaLymphoma, Non-Hodgkin The Alvin and Lois Lapidus Cancer Institute 27
Not applicableUnknownNCT05840289What this trial is testingA Study on Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive B-LymphomaWho this might be right forAggressive B-Cell Non-Hodgkin Lymphoma University Hospital, Geneva 94
Not applicableLooking for participantsNCT05326308What this trial is testingZanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular LymphomaWho this might be right forWaldenström's MacroglobulinemiaChronic Lymphocytic LeukemiaMarginal Zone Lymphoma+1 more iOMEDICO AG 845
Early research (Phase 1)Study completedNCT01535989What this trial is testingStudy of Inotuzumab Ozogamicin + Temsirolimus in Patients With Relapsed or Refractory CD22+ B-cell NHLymphomaWho this might be right forB-cell Lymphoma Refractory Cristiana Sessa 25
Large-scale testing (Phase 3)Looking for participantsNCT06717347What this trial is testingEvaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)Who this might be right forDiffuse Large B-Cell Lymphoma Merck Sharp & Dohme LLC 1,046
Testing effectiveness (Phase 2)Study completedNCT00118326What this trial is testingDonor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous DiseaseWho this might be right forKidney CancerLeukemiaLymphoma+3 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00689169What this trial is testingTargeted Intensification With ZBEAM and Autologous Stem Cell Transplantation in Patients With High-grade B-Cell LymphomaWho this might be right forLymphoma, Large Cell, Diffuse Lymphoma Study Association 75
Not applicableLooking for participantsNCT05366569What this trial is testingBio-CAR-T BS StudyWho this might be right forDiffuse Large B Cell Lymphoma (DLBCL)Primary Mediastinal Large B-cell Lymphoma (PMBCL)Acute Lymphoblastic Leukemia (ALL) Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 45
Testing effectiveness (Phase 2)Looking for participantsNCT06834529What this trial is testingCAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and LymphomaWho this might be right forRelapsed or Refractory B Cell Leukemia and Lymphoma Affiliated Hospital to Academy of Military Medical Sciences 20
Early research (Phase 1)WithdrawnNCT06003179What this trial is testingOptimizing Lymphodepletion to Improve Outcomes in Patients Receiving Cell Therapy With KymriahWho this might be right forLymphoma, Large B-Cell, Diffuse University Health Network, Toronto
Early research (Phase 1)UnknownNCT04381741What this trial is testingCD19 CAR-T Expressing IL7 and CCL19 Combined With PD1 mAb for Relapsed or Refractory Diffuse Large B Cell LymphomaWho this might be right forDiffuse Large B-cell Lymphoma Second Affiliated Hospital, Zhejiang University, School of Medicine 24
Not applicableNo Longer AvailableNCT04705454What this trial is testingLoncastixumab Tesirine (ADCT-402) Expanded Access Program (EAP) for Patients With Relapsed/Refractory Diffuse Large B-Cell LymphomaWho this might be right forRelapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) ADC Therapeutics S.A.
Testing effectiveness (Phase 2)Ended earlyNCT02258529What this trial is testingIdelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic LymphomaWho this might be right forFollicular LymphomaSmall Lymphocytic Lymphoma Gilead Sciences 10
Early research (Phase 1)Ended earlyNCT02706405What this trial is testingJCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin LymphomaWho this might be right forDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Diffuse Large B-Cell LymphomaRecurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma+3 more Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00299494What this trial is testingStudy Evaluating Inotuzumab Ozogamicin [CMC-544] Administered In Combination With Rituximab In Subjects With Non-Hodgkin's Lymphoma (NHL)Who this might be right forB-Cell Lymphoma Pfizer 119
Early research (Phase 1)Ended earlyNCT05618366What this trial is testingTazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin LymphomaWho this might be right forLymphoma, Non-HodgkinDiffuse Large B Cell LymphomaFollicular Lymphoma Weill Medical College of Cornell University 3